Cognex (CGNX)
(Real Time Quote from BATS)
$39.46 USD
-0.37 (-0.93%)
Updated Sep 20, 2024 09:38 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Cognex Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 838 | 1,006 | 1,037 | 811 | 726 |
Cost Of Goods | 236 | 284 | 277 | 206 | 190 |
Gross Profit | 601 | 722 | 760 | 605 | 536 |
Selling & Adminstrative & Depr. & Amort Expenses | 471 | 476 | 445 | 434 | 393 |
Income After Depreciation & Amortization | 131 | 246 | 315 | 171 | 143 |
Non-Operating Income | 5 | 4 | 4 | 16 | 20 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 135 | 251 | 319 | 187 | 163 |
Income Taxes | 22 | 35 | 39 | 11 | -41 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 113 | 216 | 280 | 176 | 204 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 113 | 216 | 280 | 176 | 204 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 154 | 271 | 340 | 198 | 167 |
Depreciation & Amortization (Cash Flow) | 24 | 25 | 25 | 28 | 24 |
Income After Depreciation & Amortization | 131 | 246 | 315 | 171 | 143 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 173.40 | 174.87 | 179.92 | 176.59 | 175.27 |
Diluted EPS Before Non-Recurring Items | 0.73 | 1.31 | 1.50 | 1.00 | 1.16 |
Diluted Net EPS (GAAP) | 0.65 | 1.23 | 1.56 | 1.00 | 1.16 |
Fiscal Year end for Cognex Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 239.29 | 210.80 | 196.67 | 197.24 | 242.51 |
Cost Of Goods | 72.69 | 68.86 | 61.63 | 54.47 | 62.83 |
Gross Profit | 166.60 | 141.94 | 135.04 | 142.77 | 179.68 |
SG&A, R&D, and Dept/Amort Expenses | 128.14 | 127.74 | 122.31 | 112.14 | 114.51 |
Income After SG&A, R&D, and Dept/Amort Expenses | 38.46 | 14.20 | 12.73 | 30.63 | 65.17 |
Non-Operating Income | 3.11 | 3.36 | 1.63 | -3.64 | 2.60 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 41.57 | 17.57 | 14.35 | 27.00 | 67.78 |
Income Taxes | 5.36 | 5.54 | 3.13 | 8.09 | 10.30 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 36.21 | 12.02 | 11.23 | 18.92 | 57.47 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 36.21 | 12.02 | 11.23 | 18.92 | 57.47 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 172.73 | 172.59 | 172.57 | 173.35 | 173.62 |
Diluted EPS Before Non-Recurring Items | 0.17 | 0.05 | 0.11 | 0.10 | 0.32 |
Diluted Net EPS (GAAP) | 0.21 | 0.07 | 0.06 | 0.11 | 0.33 |